Paul Ness
Overview
Explore the profile of Paul Ness including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
506
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Koepsell S, Stolla M, Sedjo R, Carson J, Knudson M, Cook R, et al.
Transfusion
. 2024 Feb;
64(3):457-465.
PMID: 38314476
Background: The Mirasol® Pathogen Reduction Technology System was developed to reduce transfusion-transmitted diseases in platelet (PLT) products. Study Design And Methods: MiPLATE trial was a prospective, multicenter, controlled, randomized, non-inferiority...
2.
Whitman G, Kramer R, Tanaka K, Holcomb J, Fitzpatrick G, Raphael J, et al.
JTCVS Open
. 2023 Apr;
13:232-241.
PMID: 37063119
Objective: Dimethylsulfoxide-cryopreserved platelets are being evaluated for treatment of acute hemorrhage in patients with thrombocytopenia or platelet dysfunction when liquid stored platelets are unavailable. Patients undergoing cardiac surgery with cardiopulmonary...
3.
Liang S, Liu Z, Wang S, Liu J, Shi L, Mao W, et al.
PLoS One
. 2020 Dec;
15(12):e0243650.
PMID: 33347449
Human immunodeficiency virus-1 (HIV-1) exhibits high diversity and complexity in China, challenging the disease surveillance and antiretroviral therapy. Between July 1, 2014 and January 30, 2017, we investigated the profiles...
4.
Lu W, Delaney M, Flegel W, Ness P, Ratcliffe N, Triulzi D, et al.
Transfusion
. 2020 Feb;
60(4):675-681.
PMID: 32027394
The United States Food and Drug Administration Final Guidance for Industry titled, "Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of...
5.
Zeng P, Liu J, Zhang C, Zhang B, Liu W, Huang M, et al.
Transfusion
. 2020 Jan;
60(2):326-333.
PMID: 31912898
Background: In China, there is a rising concern on the increasing trends of HIV infections in high-risk groups, who make blood donations that might potentially challenge the blood safety. Analyses...
6.
Gottschall J, Wu Y, Triulzi D, Kleinman S, Strauss R, Zimrin A, et al.
Transfusion
. 2019 Dec;
60(1):46-53.
PMID: 31850522
Background: Using the Recipient and Donor Epidemiology Study-III (REDS-III) recipient and donor databases, we performed a retrospective analysis of platelet use in 12 US hospitals that were participants in REDS-III....
7.
Shi L, Liu Y, Wang J, Zeng P, Gao Z, Wang S, et al.
Transfusion
. 2019 Dec;
60(1):117-125.
PMID: 31845344
Background: Previous data, although scant, indicated that the incidence of HIV in China has increased over the past decade. There is a growing concern about the impact of the HIV...
8.
Fu P, Lv Y, Zhang H, Liu C, Wen X, Ma H, et al.
Transfusion
. 2019 Jul;
59(9):2913-2921.
PMID: 31271469
Background: Hepatitis C virus (HCV) is an important transfusion-transmitted virus with global significance. The objective of this study was to evaluate the HCV prevalence and incidence among Chinese blood donors...
9.
Carson J, Liu Y, Ness P, Zaccaro D, Wu B, Meng C, et al.
Transfusion
. 2019 Jun;
59(9):2820-2826.
PMID: 31150566
Background: The number of red blood cell units transfused per capita in China is lower than in western countries and the reason(s) for the difference is unknown. Study Design And...
10.
Atreya C, Glynn S, Busch M, Kleinman S, Snyder E, Rutter S, et al.
Transfusion
. 2019 May;
59(9):3002-3025.
PMID: 31144334
No abstract available.